Bio-PAPPEL SAB de CV (BMV:PAPPEL *) agreed to acquire Corporación Scribe, S.A.P.I. de C.V. on August 25, 2014. The transaction is subject to approval by the Mexican Antitrust Authority and Scribe's bondholders. The transaction is expected to close in November.

On September 24, 2014, it was announced that the transaction has received approvals from the debtholders of Corporación Scribe. The deal has been approved by the shareholders of Bio-PAPPEL as of May 22, 2015. As of May 26, 2015, Bio-PAPPEL signed a long-term loan agreement for $255 million (MXN 3.89 billion) to cover current liabilities and partly fund the transaction by taking $55 million (MXN 839 million) . As of MAy 29, 2015, Mexico's antitrust commission approved the transaction. The transaction is expected to be completed within days.

Emilio J. Alvarez-Farré, Juan Delgado, Juan Manuel González Bernal, Miguel Yturbe Redo, José A. Butrón Quintero and Adriana Garcia-Cuellar of Greenberg Traurig, S.C acted as legal advisor to Bio-PAPPEL SAB de CV (BMV:PAPPEL *). Alberto de la Parra and Salvador Gallo Jones Day acted as legal advisors for Corporación Scribe, S.A.P.I. de C.V. shareholders. Credit Suisse Securities (USA) LLC acted as exclusive financial advisor to Corporación Scribe. The conversions are done using www.oanda.com.

Bio-PAPPEL SAB de CV (BMV:PAPPEL *) completed the acquisition of Corporación Scribe, S.A.P.I. de C.V. on June 5, 2015. The deal has been approved by competition authority Cofece.